No Relief for Diabetics as the Inflation Reduction Act Becomes Law

A cap on the price of the diabetes medication insulin at $35 per month for people with private medical insurance remains elusive even in a new sweeping budget package meant to bring financial relief to Americans.

#DiabetesMedication #Insulin #InflationReductionAct #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

You May Also Like